Boehringer Ingelheim Venture Fund co-led a $13.3m round for the immuno-oncoclogy startup, which was spun out of University of Duisburg-Essen’s and University of Düsseldorf.

The cancer therapy developer boosted a series B round led by Novo and backed by Celgene to $75.2m, with both corporates contributing to the latest tranche.

Jackson Laboratory cancer drug spinout Cyteir Therapeutics extended its series B round thanks to investors including Osage University Partners and Novo Holdings.

Atomico has led $56m series B round for Cambridge-allied rare disease therapy developer Healx, which also welcomed Intel Capital as a new shareholder.

Sequis Life led a series C round for online healthcare and insurance portal Alodokter that included Philips and existing investor SoftBank Ventures Asia.

Lilly Asia Ventures returned for the respiratory disease drug developer's series B round, having co-led its $85m series A last year.

University of Michigan has generated 86 spinouts over the past five years after setting a new record of 22 during its most recent financial year.

Ahren Innovation Capital has led a $16m initial series A tranche for Mogrify, co-founded by researchers from Bristol, Monash and Duke universities.

The Chernin Group-backed personalised care provider plans to use the series B funding to expand into new cities and take its telemedicine offering nationwide.

Humana provided $20m for healthcare assistance platform Accolade through the widening of a strategic agreement signed in March.